Vectura, a FTSE250 company listed on the London Stock Exchange (LSE: VEC), is an industry-leading device and formulation business for inhaled airways products offering a uniquely integrated inhaled drug delivery platform. With their extensive range of device and formulation technologies, integrated capabilities and collaborations, they are a leader in the development of inhalation products…More, increasing their ability to help patients suffering from respiratory diseases.
REPORT RATINGS
4.7 / 5.0 (77)
Vectura Group plc reports have an aggregate usefulness score of 4.7 based on 77 reviews.